Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy

被引:0
作者
Toto, Lisa [1 ]
Ares, Ignacio [2 ]
Quarta, Alberto [1 ]
Viggiano, Pasquale [3 ]
Ruggeri, Marialudovica [1 ]
Formenti, Federico [1 ]
Boscia, Giacomo [3 ]
Porreca, Annamaria [4 ]
Di Nicola, Marta [4 ]
Boscia, Francesco [3 ]
Mastropasqua, Rodolfo [5 ]
机构
[1] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Viale Abruzzo,322, I-66100 Chieti, CH, Italy
[2] Potsdamer Augenklin Albrecht von Graefe Haus GmbH, Dept Ophthalmol Res Sci, Hans-Thoma-Str 11-2, D-14467 Potsdam, OG, Germany
[3] Univ Bari Aldo Moro, Dept Translat Biomed Neurosci, Piazza Umberto 1 1, I-70121 Bari, BA, Italy
[4] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Lab Biostat, Via Vestini,31, I-66100 Chieti, CH, Italy
[5] Univ G D Annunzio Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Via Vestini,31, I-66100 Chieti, CH, Italy
关键词
Navigated subthreshold laser; Photodynamic therapy; Central serous chorioretinopathy; Spectral domain optical coherence tomography; VERTEPORFIN;
D O I
10.1007/s00417-024-06666-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposeTo compare the visual and anatomical results of navigated subthreshold micropulse laser (nSML) and photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSCR).MethodsPatients who underwent either half-dose PDT or nSML for the management of chronic CSCR were included in this study. Comprehensive ophthalmic examination, fundus autofluorescence, and spectral domain optical coherence tomography (SD-OCT) were performed at baseline and at 1-, 3-, and 6-month follow-up visits after nSML or PDT. Fluorescein angiography and indocyanine green angiography were performed only at baseline. Main outcome measures were best corrected visual acuity (BCVA), central macular thickness (CMT), subretinal fluid (SRF), subfoveal choroidal thickness (SFCT), and choroidal vascularization index (CVI) that were collected at baseline and at each follow-up visit for up to 6 months.ResultsForty-two eyes of 42 patients (PDT group-20 eyes, nSML group-22 eyes) affected by chronic CSCR were enrolled. At 6-month follow-up, no significant differences were observed between the nSML group compared to the PDT group in BCVA (0.10 [0.00; 0.20]) and 0.10 [0.10; 0.10], respectively, p=0.69, and between some OCT parameters, namely CMT and CVI. SFCT was significantly reduced in the PDT group more than in the nSML group (p=0.01). Twelve eyes (60%) in the PDT group had complete resolution of the SRF at 6 months compared to 8 eyes (36.4%) in the nSML group, but the difference was not statistically significant (p=0.14).ConclusionResults from patients treated with PDT and nSML showed that, at 6 months, no significant differences except for choroidal thickness. nSML is less invasive than PDT and can be used as an effective alternative to PDT.What is knownTreating chronic CSCR is a therapeutic conundrum for clinicians because of a lack of definitive consensus over remediation options, two of which are photodynamic therapy (PDT) and navigated subthreshold micropulse laser (nSML) therapy.This study showsResults from patients treated with PDT and nSML showed no significant differences except for choroidal thickness.Even though patients treated with PDT recovered more quickly, retreatment was necessary due to fluid recollection.Although patients treated with nSML also needed retreatment, nSML is less invasive than PDT and can be used as an effective alternative to PDT.
引用
收藏
页码:405 / 414
页数:10
相关论文
共 29 条
  • [1] Advances in the treatment of central serous chorioretinopathy
    Abouammoh, Marwan A.
    [J]. SAUDI JOURNAL OF OPHTHALMOLOGY, 2015, 29 (04) : 278 - 286
  • [2] Choroidal vascularity index: a step towards software as a medical device
    Betzler, Bjorn Kaijun
    Ding, Jianbin
    Wei, Xin
    Lee, Jia Min
    Grewal, Dilraj S.
    Fekrat, Sharon
    Sadda, Srinivas R.
    Zarbin, Marco A.
    Agarwal, Aniruddha
    Gupta, Vishali
    Schmetterer, Leopold
    Agrawal, Rupesh
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (02) : 149 - 155
  • [3] The anti-inflammatory mechanisms of Hsp70
    Borges, Thiago J.
    Wieten, Lotte
    van Herwijnen, Martijn J. C.
    Broere, Femke
    van der Zee, Ruurd
    Bonorino, Cristina
    van Eden, Willem
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [4] Breukink MB, 2017, CLIN OPHTHALMOL, V11, P39, DOI 10.2147/OPTH.S115685
  • [5] Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
    Breukink, Myrte B.
    Downes, Susan M.
    Querques, Giuseppe
    van Dijk, Elon H. C.
    den Hollander, Anneke I.
    Blanco-Garavito, Rocio
    Keunen, Jan E. E.
    Souied, Eric H.
    MacLaren, Robert E.
    Hoyng, Carel B.
    Fauser, Sascha
    Boon, Camiel J. F.
    [J]. TRIALS, 2015, 16
  • [6] Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy - One-year results of a randomized controlled trial
    Chan, Wai-Man
    Lai, Timothy Y. Y.
    Lai, Ricky Y. K.
    Liu, David T. L.
    Lam, Dennis S. C.
    [J]. OPHTHALMOLOGY, 2008, 115 (10) : 1756 - 1765
  • [7] Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
    Chan, WM
    Lam, DSC
    Lai, TYY
    Tam, BSM
    Liu, DTL
    Chan, CKM
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (12) : 1453 - 1458
  • [8] GASS JDM, 1967, AM J OPHTHALMOL, V63, P573
  • [9] LONG-TERM FOLLOW-UP OF CENTRAL SEROUS CHORIORETINOPATHY
    GILBERT, CM
    OWENS, SL
    SMITH, PD
    FINE, SL
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1984, 68 (11) : 815 - 820
  • [10] Management of chronic central serous chorioretinopathy
    Hanumunthadu, Daren
    Tan, Anna C. S.
    Singh, Sumit Randhir
    Sahu, Niroj Kumar
    Chhablani, Jay
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2018, 66 (12) : 1704 - +